X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-18 | SYRS | Stephens Kristin | Chief Development Officer | S - Sale | $0.22 | -36,133 | 0 | -100% | -$7,949 | ||||||
2024-11-18 | SYRS | Roth David | Chief Medical Officer | S - Sale | $0.20 | -12,099 | 0 | -100% | -$2,382 | ||||||
2024-11-19 | SYRS | Quirk Gerald E | Chief Legal, Compliance Offic | S - Sale | $0.22 | -46,657 | 0 | -100% | -$10,321 | ||||||
2024-11-18 | SYRS | Chee Conley | Pres, CEO | S - Sale | $0.20 | -134,797 | 0 | -100% | -$26,932 | ||||||
2024-11-18 | SYRS | Haas Jason | CFO | S - Sale | $0.21 | -137,803 | 0 | -100% | -$28,980 | ||||||
| M | 2024-09-10 | SYRS | Chee Conley | Pres, CEO | P - Purchase | $1.61 | +100,000 | 122,504 | +444% | +$160,680 | |||||
| M | 2024-09-10 | SYRS | Haas Jason | CFO | P - Purchase | $1.61 | +100,000 | 124,552 | +407% | +$161,240 | |||||
2024-06-28 | SYRS | Young Richard A | Dir | S - Sale | $5.12 | -34,837 | 8,000 | -81% | -$178,365 | ||||||
2024-04-03 | SYRS | Roth David | Chief Medical Officer | S - Sale | $4.95 | -10,451 | 0 | -100% | -$51,732 | ||||||
| D | 2024-04-02 | SYRS | Roth David | Chief Medical Officer | S - Sale+OE | $4.98 | -150 | 10,451 | -1% | -$747 | |||||
2023-12-21 | SYRS | Akkaraju Srinivas | Dir | P - Purchase | $4.42 | +904,977 | 1,789,093 | +102% | +$3,999,998 | ||||||
2023-12-12 | SYRS | Roth David | Chief Medical Officer | S - Sale | $4.95 | -6,287 | 0 | -100% | -$31,121 | ||||||
2023-12-06 | SYRS | Roth David | Chief Medical Officer | S - Sale | $3.95 | -6,287 | 6,287 | -50% | -$24,834 | ||||||
2023-07-31 | SYRS | Roth David | Chief Medical Officer | S - Sale | $3.95 | -7,348 | 0 | -100% | -$29,025 | ||||||
2023-07-17 | SYRS | Olson Eric R | Chief Scientific Officer | S - Sale | $3.50 | -689 | 6,661 | -9% | -$2,412 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |